Heartstitch, Inc.

Heartstitch, Inc.
About Us
Follow us:
Share:
Subscribe:

About Us

About HeartStitch: HeartStitch®, Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on the innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures. HeartStitch® manufactures and markets the NobleStitch™ EL under and exclusive license from Nobles Medical Technologies II, Inc. NobleStitch™ EL is FDA cleared for vascular suturing in the United States and CE Marked for cardio-vascular suturing and PFO closure in the European Union. HeartStitch® is a registered trademark of HeartStitch®, Inc. For more on HeartStitch® visit www.HeartStitch.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

NobleStitch ASD Closure Case Highlights Septal Defect Closure Revolution At CSI Conference

Fri, Jul 22, 2016 14:35 CET

Prof. Nobles Presented Revolutionary First In Man Clinical Case Of ASD (Atrial Septal Defect) Closure And ASA (Atrial Septal Aneurysm) Repair At Structural Heart ConferenceFrankfurt, Germany—July 20, 2016—Nobles Medical Technologies II (NMT2) continued to surprise the more than 900 cardiologist and cardiac-specialist attendees at the CSI conference on structural heart interventions with its presentation of the first-ever ASA repair, ASD and PFO closure case. Prof. Anthony Nobles, CEO and Chief Clinical Specialist of NMT2, presented the case in detail, highlighting its unique series

NobleStitch ™ PFO Multicenter Data Amplifies Renewed Interest at CSI Conference

Mon, Jul 18, 2016 11:49 CET

Successful Multi-Center Data For NobleStitch™ EL Presented at Structural Heart Conference Highlights the Benefits of Device-less PFO ClosureFrankfurt, Germany—July 18, 2016—The expanded use of NobleStitch™ EL across many global markets has led to a steadily increasing body of data on real-world procedure outcomes. Dr. Michael Mullen presented the first multi-center data—collected across the UK, Sweden, Germany, Italy, and Kazakhstan—to the more than 900 cardiologists and cardiac specialist from around the world attending the CSI Structural Heart Conference in Frankfurt, Germany. The data

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

NobleStitch ASD Closure Case Highlights Septal Defect Closure Revolution At CSI Conference

NobleStitch ™ PFO Multicenter Data Amplifies Renewed Interest at CSI Conference